top of page
Obefazimod in Focus:
Revolutionizing IBD Through a New Mechanism of Action
Thursday, February 19, 2026 • 14:00–14:20 CEST • Meeting Room A10
Thursday, February 19, 2026
14:00–14:20 CEST
Meeting Room A10
Obefazimod is an investigational agent not approved by any health regulatory agencies.
bottom of page